Over 2000 Patients Treated With Ellipse Technologies, Inc.’ MAGEC System

Treatment for Children with Spinal Deformities Continues Evidence-Driven, Rapid Adoption

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ellipse Technologies, Inc., a global medical device company, announced today that its proprietary MAGEC (MAGnetic Expansion Control) spinal bracing and distraction system has been used to treat more than 2000 patients. The company also reported that more than 25% of these patients were treated in 2015, demonstrating acceleration of adoption of the technology.

“I expect that this technology will play a key role in decreasing the number of surgeries these young patients have to undergo. The decrease in surgeries will translate into decreased complication rates and cost.”

The MAGEC system has introduced a quality of life enhancing option for young patients with early onset scoliosis (EOS). The system consists of magnetically-driven adjustable spinal rods and an external remote control device. It is the only non-invasively adjustable distraction technology system available for the treatment of EOS. The innovative technology eliminates painful repeated surgeries for distractions, typically performed every six months, which are required by other EOS treatment options.

By using an external remote control to adjust the rods, the MAGEC system can be non-invasively distracted in seconds in a precise, controlled manner after the initial implantation. This system enables a treatment technique advancement that is being increasingly adopted by surgeons all over the world who treat children with EOS, as evidenced by the more than 2000 patients treated to date.

“Ellipse's focus on revolutionizing treatment of children with early onset scoliosis continues,” said Peter F. Sturm, M.D., Director of the Crawford Spine Center at Cincinnati Children’s Hospital. “I expect that this technology will play a key role in decreasing the number of surgeries these young patients have to undergo. The decrease in surgeries will translate into decreased complication rates and cost.”

The elimination of repeated surgical distractions drastically reduces hospitalization, neuro-monitoring, anesthesia exposure, and the incidence of infection, enabling better outcomes for these children and providing overall cost savings in their treatment.

“Knowing that our MAGEC system has enabled surgeons to save more than 2000 children from multiple surgeries is tremendously rewarding,” said Ellipse’s President and CEO, Ed Roschak. “This demonstrates how well-received by the clinician and patient communities the MAGEC system has been.”

Roschak added that in the last 12 months, more than 150 new surgeons started utilizing the MAGEC system.

The MAGEC system is intended for skeletally immature patients less than 10 years of age with severe progressive spinal deformities associated with or at risk for Thoracic Insufficiency Syndrome.

About Ellipse Technologies

Ellipse Technologies, Inc. is a privately held medical device company located in Aliso Viejo, California. The company is dedicated to the design, development, and commercialization of its evolving proprietary technology platform for orthopedic and spinal applications. This technology enables precisely controlled, non-invasive post-operative adjustment of implants allowing surgeons to better address a range of clinical needs. In addition to the MAGEC system, Ellipse markets the PRECICE limb lengthening system. Ellipse is developing additional products to improve clinical outcomes in a variety of applications through its collaboration with surgeon thought leaders. For more information, visit www.ellipse-tech.com.